Extragonadal Effects of Follicle-Stimulating Hormone on Osteoporosis and Cardiovascular Disease in Women during Menopausal Transition

Dongxing Zhu, Xiaosa Li, Vicky E Macrae, Tommaso Simoncini, Xiaodong Fu

Research output: Contribution to journalReview articlepeer-review

Abstract

The risk of osteoporosis and cardiovascular disease increases significantly in postmenopausal women. Until recently, the underlying mechanisms have been primarily attributed to estrogen decline following menopause. However, follicle-stimulating hormone (FSH) levels rise sharply during menopausal transition and are maintained at elevated levels for many years. FSH receptor has been detected in various extragonadal sites, including osteoclasts and endothelial cells. Recent advances suggest FSH may contribute to postmenopausal osteoporosis and cardiovascular disease. Here, we review the key actions through which FSH contributes to the risk of osteoporosis and cardiovascular disease in women as they transition through menopause. Advancing our understanding of the precise mechanisms through which FSH promotes osteoporosis and cardiovascular disease may provide new opportunities for improving health-span for postmenopausal women.

Original languageEnglish
Pages (from-to)571-580
JournalTrends in Endocrinology and Metabolism
Volume29
Issue number8
Early online date5 Jul 2018
DOIs
Publication statusE-pub ahead of print - 5 Jul 2018

Keywords

  • Follicle-stimulating hormone
  • postmenopause;
  • osteoporosis
  • cardiovascular disease
  • extragonadal effects

Fingerprint

Dive into the research topics of 'Extragonadal Effects of Follicle-Stimulating Hormone on Osteoporosis and Cardiovascular Disease in Women during Menopausal Transition'. Together they form a unique fingerprint.

Cite this